medigraphic.com
ISSN 1561-297X (Print)

2016, Number 1

<< Back Next >>

Rev Cubana Estomatol 2016; 53 (1)

Oral candidiasis in HIV-AIDS patients associated with CD4 T lymphocyte levels and antiretroviral therapy

Harris RJ, Herrera HA

Language: Spanish
References: 26
Page: 9-14
PDF size: 227.46 Kb.


ABSTRACT

Introduction: oral candidiasis is the most common opportunistic infection in HIV-infected patients, and on many occasions it is the first manifestation of the disease. Objective: determine the association between oral candidiasis, CD4 lymphocyte levels and antiretroviral treatment in HIV/AIDS patients. Methods: a descriptive cross-sectional study was conducted. The study population was 141 patients diagnosed as HIV-positive. All clinical intraoral examinations were performed by the same examiner. Data about CD4 lymphocyte levels and antiretroviral therapy were obtained from the patients’ medical records. The information was processed with the statistical package Stata v11. Results: 66.7% of the study population were men. Sexual transmission was the most common form of transmission (96%). Prevalence of oral manifestations associated with HIV was 59.5%; the most common form of the disease was pseudomembranous candidiasis (31.3%), followed by erythematous candidiasis (4.2%). With respect to pseudomembranous candidiasis and CD4 levels, 22 patients had CD4 values below 200 cell/mL3, and 29 were undergoing antiretroviral therapy with two drug groups: IP/INTR. Conclusion: pseudomembranous candidiasis is highly correlated with CD4 lymphocyte levels below 200 cell/mm3. Patients under antiretroviral monotherapy presented less candidiasis than those under bitherapy.


REFERENCES

  1. Dos Santos Abrantes PM, McArthur CP, Africa CW. Multi-drug resistant oral Candida species isolated from HIV-positive patients in South Africa and Cameroon. Diagnostic Microbiology and Infectious Disease. 2014;79(2):222-7.

  2. Katiraee F, Khalaj V, Khosravi AR, Hajiabdolbaghi M. Sequences type analysis of Candida albicans isolates from Iranian human immunodeficiency virus infected patients with oral candidiasis. Acta Médica Iranica. 2014;52(3):187-91.

  3. Li YY, Chen WY, Li X, Li HB, Li HQ, Wang L, He L, Yang XP, Wang XC, Huang YL, Yao YG. Asymptomatic oral yeast carriage and antifungal susceptibility profile of HIV-infected patients in Kunming, Yunnan Province of China. BMC Infect Dis. 2013 Jan 28;13:46. doi: 10.1186/1471-2334-13-46.

  4. Castro LA, Alvarez MI, Martinez E. Pseudomembranous candidiasis in HIV/AIDS patients in Cali, Colombia. Mycopathologia. 2013;175(1-2):91-8.

  5. Nweze EI, Ogbonnaya UL. Oral Candida isolates among HIV-infected subjects in Nigeria. J Microbiol Immunol Infect. 2011;44(3):172-7.

  6. Li YY, Chen WY, Li X, Li HB, Li HQ, Wang L, et al. Asymptomatic oral yeast carriage and antifungal susceptibility profile of HIV-infected patients in Kunming, Yunnan Province of China. BMC Infectious Diseases. 2013;13:46.

  7. Unqueira JC, Vilela SF, Rossoni RD, Barbosa JO, Costa AC, Rasteiro VM, et al. Oral colonization by yeasts in HIV-positive patients in Brazil. Revista do Instituto de Medicina Tropical de Sao Paulo. 2012;54(1):17-24.

  8. Mwangosi IE, Tillya J. Oral lesions associated with HIV/AIDS in HIV-seropositive patients attending a counselling and treatment centre in Dar es Salaam. Int Dent J. 2012;62(4):197-202.

  9. Jose R, Chandra S, Puttabuddi JH, Vellappally S, Al Khuraif AA, Halawany HS, et al. Prevalence of oral and systemic manifestations in pediatric HIV cohorts with and without drug therapy. Current HIV Research. 2013;11(6):498-505.

  10. Moris DV, Melhem MS, Martins MA, Souza LR, Kacew S, Szeszs MW, et al. Prevalence and antifungal susceptibility of Candida parapsilosis complex isolates collected from oral cavities of HIV-infected individuals. Journal of Medical Microbiology. 2012;61(Pt 12):1758-65.

  11. McLean AT, Wheeler EK, Cameron S, Baker D. HIV and dentistry in Australia: clinical and legal issues impacting on dental care. Australian dental journal. 2012;57(3):256-70.

  12. Bodhade AS, Ganvir SM, Hazarey VK. Oral manifestations of HIV infection and their correlation with CD4 count. J Oral Sci. 2011;53(2):203-11.

  13. Mastrolorenzo A, Giomi B, Tiradritti L, Zuccati G. Oral manifestations of sexually transmitted infections. Giornale italiano di dermatologia e venereologia : organo ufficiale, Societa italiana di dermatologia e sifilografia. 2012;147(4):373-88.

  14. Bhayat A, Yengopal V, Rudolph M. Predictive value of group I oral lesions for HIV infection. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2010;109(5):720-3.

  15. Carpio E, López V, Fardales V, Benítez I. Oral manifestations of HIV infection in adult patients from the province of Sancti Spiritus, Cuba. J Oral Pathol Med. 2009;38(1):126-31.

  16. Ramírez-Amador V, Ponce-de-León S, Anaya-Saavedra G, Crabtree Ramírez B, Sierra-Madero J. Oral lesions as clinical markers of highly active antiretroviral therapy failure: a nested case-control study in Mexico City. Clin Infect Dis. 2007;45(7):925-32.

  17. Khatibi M, Moshari AA, Jahromi ZM, Ramezankhani A. Prevalence of oral mucosal lesions and related factors in 200 HIV(+) /AIDS Iranian patients. J Oral Pathol Med. 2011;40(8):659-64.

  18. Rodríguez M. Manifestaciones orales asociadas con la infección por VIH-SIDA. Rev Cubana Estomatol. 2005 Ene;42(1):1-6.

  19. Bascones A, Serrano C, Campo J. Manifestaciones de la infección por el virus de la inmunodeficiencia humana en la cavidad bucal. Med Clin (Barc). 2003;120(11):426-34.

  20. Wen Y, Zhou Y, Wang W, Wang Y, Lu X, Sun CM, et al. Baseline factors associated with mortality within six months after admission among hospitalized HIV-1 patients in Shenyang, China. Internal Medicine. 2014;53(21):2455-61.

  21. Zhang X, Reichart PA, Song Y. Oral manifestations of HIV/AIDS in China: a review. Oral Maxillofac Surg. 2009;13(2):63-8.

  22. Guteta S, Feleke Y, Fekade D, Neway M, Diro E. Prevalence of oral and perioral manifestations in HIV positive adults at Tikur Anbessa Teaching Hospital Addis Ababa, Ethiopia. Ethiop Med J. 2008;46(4):349-57.

  23. Tirwomwe JF, Rwenyonyi CM, Muwazi LM, Besigye B, Mboli F. Oral manifestations of HIV/AIDS in clients attending TASO clinics in Uganda. Clin Oral Investig. 2007;11(3):289-92.

  24. Brevis Azocar P, Pérez Marín E, Abaca C P, Coronado Gallardo C, Cantín López M. Asociación de LT-CD4 y carga viral con candidiasis bucal en pacientes VIH/SIDA en Talca, Chile. Rev Cubana Estomatol [revista en Internet]. 2009 Dic [citado 23 de enero de 2015];46(4):16-22. Disponible en: http://scieloprueba.sld.cu/scielo.php?script=sci_arttext&pid=S0034-75072009000400002&lng=es

  25. Sontakke SA, Umarji HR, Karjodkar F. Comparison of oral manifestations with CD4 count in HIV-infected patients. Indian J Dent Res. 2011;22(5):732.

  26. Delgado AC, de Jesus Pedro R, Aoki FH, Resende MR, Trabasso P, Colombo AL, de Oliveira MS, Mikami Y, Moretti ML. Clinical and microbiological assessment of patients with a long-term diagnosis of human immunodeficiency virus infection and Candida oral colonization. Clin Microbiol Infect. 2009;15(4):364-71.




2020     |     www.medigraphic.com